New antibiotic gepotidacin tested in kids for first time

This early-stage study will give a single dose of the experimental antibiotic gepotidacin to 20 hospitalized children aged 2 to 12 who are already receiving standard antibiotics for a bacterial infection or as a preventive measure. Researchers will measure how the drug moves through the body and check for any side effects. The goal is to gather safety and dosing information, not to treat the infection directly.